These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UNITED STATES
|
|||||
|
SECURITIES AND EXCHANGE COMMISSION
|
|||||
|
Washington, D.C. 20549
|
|||||
|
SCHEDULE 14A
|
|||||
|
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )
|
|||||
|
Filed by the Registrant ☒
|
|||||
|
Filed by a Party other than the Registrant ☐
|
|||||
|
Check the appropriate box:
|
|||||
|
☐
|
|
Preliminary Proxy Statement
|
|||
|
☐
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|||
|
☒
|
|
Definitive Proxy Statement
|
|||
|
☐
|
|
Definitive Additional Materials
|
|||
|
☐
|
|
Soliciting Material Pursuant to §240.14a-12
|
|||
|
UNITY BANCORP, INC.
|
|||||
|
(Name of Registrant as Specified In Its Charter)
|
|||||
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
|||||
|
Payment of Filing Fee (Check the appropriate box):
|
|||||
|
☒
|
|
No fee required.
|
|||
|
☐
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|||
|
|
|
(1
|
)
|
|
Title of each class of securities to which transaction applies:
|
|
|
|
(2
|
)
|
|
Aggregate number of securities to which transaction applies:
|
|
|
|
(3
|
)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
|
(4
|
)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
|
(5
|
)
|
|
Total fee paid:
|
|
☐
|
|
Fee paid previously with preliminary materials.
|
|||
|
☐
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|||
|
|
|
(1
|
)
|
|
Amount Previously Paid:
|
|
|
|
(2
|
)
|
|
Form, Schedule or Registration Statement No.:
|
|
|
|
(3
|
)
|
|
Filing Party:
|
|
|
|
(4
|
)
|
|
Date Filed:
|
|
1.
|
The election of the
four
(
4
) nominees listed in the attached proxy statement to serve on the Board of Directors for the terms set forth therein for each nominee.
|
|
2.
|
The ratification of the selection of RSM US LLP as the Company’s independent external auditors for the year ending
December 31, 2020
.
|
|
3.
|
Such other business as may properly come before the Annual Meeting and at any adjournments thereof, including whether or not to adjourn the Annual Meeting.
|
|
1.
|
The election of the
four
(
4
) nominees listed in the attached proxy statement to serve on the Board of Directors for the terms set forth therein for each nominee.
|
|
2.
|
The ratification of the selection of RSM US LLP as the Company’s independent external auditors for the year ending
December 31, 2020
.
|
|
3.
|
Such other business as may properly come before the Annual Meeting and at any adjournments thereof, including whether or not to adjourn the Annual Meeting.
|
|
Name, Age and Position with Company (1)
|
Principal Occupation During Past Five Years
|
Director Since (2)
|
Term Expires
|
|
Wayne Courtright, 72
|
Retired, Former Bank Executive Officer and Consultant
|
2004
|
2023
|
|
Director
|
|
|
|
|
David D. Dallas (3), 65
|
Chairman of the Company and the Bank;
|
1991
|
2023
|
|
Chairman
|
Chief Executive Officer of Dallas Group of America, Inc. (Chemicals)
|
|
|
|
Robert H. Dallas, II (3), 73
|
President of Dallas Group of America, Inc. (Chemicals)
|
1991
|
2023
|
|
Director
|
|
|
|
|
Peter E. Maricondo, 73
|
Retired, Former Financial Consultant
|
2004
|
2023
|
|
Director
|
|
|
|
|
Name, Age and Position with Company (1)
|
Principal Occupation During Past Five Years
|
Director Since (2)
|
Term Expires
|
|
Dr. Mark S. Brody, 67
|
Managing Member Financial Planning Analysts, LLC;
|
2002
|
2021
|
|
Director
|
Vice President of Planned Financial Programs, Inc.
|
|
|
|
Raj Patel, 65
|
CEO of Millennium Hotel Group (Hotel);
|
2007
|
2021
|
|
Director
|
CEO of 2602 Deerfield LLC (Real Estate)
|
|
|
|
Donald E. Souders, Jr. , 54
|
Attorney/Partner, Florio Perrucci Steinhardt & Cappelli LLC
|
2007
|
2021
|
|
Director
|
|
|
|
|
Dr. Mary E. Gross, 59
|
Founder, Human Edge Resources, LLC (Human Resource Consulting)
|
2009
|
2022
|
|
Director
|
|
|
|
|
James A. Hughes, 61
|
President and CEO of the Company and the Bank
|
2002
|
2022
|
|
President, CEO and Director
|
|
|
|
|
Aaron Tucker (3), 57
|
President, Tucker Enterprises; Real Estate Builder and Investor
|
2014
|
2022
|
|
Director
|
|
|
|
|
Allen Tucker (3), 93
|
Chairman, Tucker Enterprises; Real Estate Builder and Investor
|
1995
|
2022
|
|
Vice Chairman
|
|
|
|
|
Name
|
Audit
|
Human Resources/Compensation
|
Executive Loan
|
Corporate Governance and Nominating
|
Risk Management
|
|
Dr. Mark S. Brody
|
Member
|
Chairman
|
Member
|
|
Member
|
|
Wayne Courtright
|
Member
|
|
Vice Chairman
|
|
Member
|
|
David D. Dallas
|
Member
|
|
Member
|
|
Chairman
|
|
Robert H. Dallas, II
|
|
|
Member
|
Member
|
Member
|
|
Dr. Mary E. Gross
|
Member
|
Member
|
|
Chairman
|
Member
|
|
Peter E. Maricondo
|
Chairman
|
Member
|
|
Member
|
Member
|
|
Raj Patel
|
|
Member
|
Member
|
|
Member
|
|
Donald E. Souders, Jr.
|
|
Member
|
|
Member
|
Member
|
|
Aaron Tucker
|
Member
|
|
Member
|
Member
|
Member
|
|
Allen Tucker
|
|
|
Chairman
|
|
Vice Chairman
|
|
•
|
Developing and recommending to the Board a set of corporate governance principles applicable to the Company, and fulfilling the duties of the Committee as specified in such governance principles;
|
|
•
|
Assisting the Board in determining the size and composition of the Board of Directors and its Committees;
|
|
•
|
Assisting the Board in identifying qualified individuals to be considered for nomination by the Board for election as directors at any meeting of shareholders, including considering proposals made by shareholders and others to nominate specific individuals to the Board of Directors; and
|
|
•
|
Overseeing the annual evaluation of the Board.
|
|
|
2019
|
2018
|
||||
|
Audit fees (1)
|
$
|
255,850
|
|
$
|
242,500
|
|
|
Audit related fees (2)
|
5,000
|
|
5,000
|
|
||
|
Total
|
$
|
260,850
|
|
$
|
247,500
|
|
|
(1)
|
Includes those fees required for reporting on the Company's consolidated financial statements.
|
|
(2)
|
Includes fees relating to the U.S. Department of Housing and Urban Development (HUD) reporting requirements.
|
|
Name and Position With Company (1)
|
Number of Shares Beneficially Owned (2)
|
Percent of Class
|
|||
|
Dr. Mark S. Brody, Director
|
419,802
|
|
(3)
|
3.85
|
%
|
|
Wayne Courtright, Director
|
119,244
|
|
(4)
|
1.09
|
%
|
|
David D. Dallas, Chairman
|
1,737,602
|
|
(5)
|
15.96
|
%
|
|
Robert H. Dallas, II, Director
|
1,737,014
|
|
(6)
|
15.95
|
%
|
|
Dr. Mary E. Gross, Director
|
21,476
|
|
(7)
|
0.20
|
%
|
|
Peter E. Maricondo, Director
|
46,006
|
|
(8)
|
0.42
|
%
|
|
Raj Patel, Director
|
42,336
|
|
(9)
|
0.39
|
%
|
|
Donald E. Souders, Jr., Director
|
22,920
|
|
(10)
|
0.21
|
%
|
|
Aaron Tucker, Director
|
58,869
|
|
(11)
|
0.54
|
%
|
|
Allen Tucker, Vice Chairman
|
370,779
|
|
(12)
|
3.40
|
%
|
|
James A. Hughes, President and Director
|
174,419
|
|
(13)
|
1.60
|
%
|
|
Alan J. Bedner, Exec. V.P. and Chief Financial Officer
|
83,564
|
|
(14)
|
0.76
|
%
|
|
Janice Bolomey, Exec. V.P. and Chief Administrative Officer
|
103,419
|
|
(15)
|
0.94
|
%
|
|
John J. Kauchak, Exec. V.P. and Chief Operating Officer
|
127,641
|
|
(16)
|
1.17
|
%
|
|
Stephen Rooney, First SVP and Chief Lending Officer
|
24,629
|
|
(17)
|
0.23
|
%
|
|
Directors and Executive Officers of the Company as a Group (15 persons)
|
3,378,085
|
|
(18)
|
30.12
|
%
|
|
5% Shareholders:
|
|
|
|
||
|
Endicott Management Company
|
660,635
|
|
(19)
|
6.07
|
%
|
|
Banc Funds Company LLC
|
856,568
|
|
(20)
|
7.87
|
%
|
|
(1)
|
The address for Endicott Management Company is 570 Lexington Avenue, 37th Floor, New York, NY 10022. The address for Banc Funds Company LLC is 20 North Wacker Drive, Suite 3300, Chicago, IL 60606-3105. The address for all other listed persons is c/o Unity Bank, 64 Old Highway 22, Clinton, New Jersey, 08809.
|
|
(2)
|
Beneficially owned shares include shares over which the named person exercises either sole or shared voting power or sole or shared investment power. It also includes shares owned (i) by a spouse, minor children or relatives sharing the same home, (ii) by entities owned or controlled by the named person, and (iii) by other persons if the named person has the right to acquire such shares within sixty (60) days by the exercise of any right or option. Unless otherwise noted, all shares are owned of record and beneficially by the named person.
|
|
(3)
|
Includes
48,400
shares held jointly with his spouse, and
9,133
shares issuable upon the exercise of immediately exercisable options. Also includes
40,102
shares registered to Financial Planning Analysts and owned by Dr. Brody;
21,274
shares in Dr. Brody’s own name;
12,705
shares in an SEP-IRA account in his own name; and
286,713
shares held in a master account at Financial Planning Analysts over which Dr. Brody has no voting authority, but has dispositive power. Also includes a total of
1,475
shares of Restricted Stock (see number 21 below for grant details).
|
|
(4)
|
Includes
63,636
shares in Mr. Courtright’s own name,
45,000
shares in an IRA in his own name and
9,133
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
1,475
shares of Restricted Stock (see number 21 below for grant details).
|
|
(5)
|
Includes
20,276
shares in Mr. David Dallas’ own name and
3,666
shares issuable upon the exercise of immediately exercisable options. Shares also disclosed as beneficially owned by Mr. Dallas are
1,711,635
shares held by Dallas Financial Holdings, LLC., which are also disclosed as beneficially owned by Mr. Robert H. Dallas, II. Also includes a total of
1,475
shares of Restricted Stock (see number 21 below for grant details) and
550
shares issued through its Dividend Reinvestment Plan.
|
|
(6)
|
Includes
19,971
shares in Mr. Robert Dallas’ own name and
3,633
shares issuable upon the exercise of immediately exercisable options. Shares also disclosed as beneficially owned by Mr. Dallas are
1,711,635
shares held by Dallas Financial Holdings, LLC., which are also disclosed as beneficially owned by Mr. David D. Dallas. Also includes a total of
1,237
shares of Restricted Stock (see number 22 below for grant details) and
538
shares issued through its Dividend Reinvestment Plan.
|
|
(7)
|
Includes
13,801
shares in Dr. Gross’ own name and
6,200
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
1,475
shares of Restricted Stock (see number 21 below for grant details).
|
|
(8)
|
Includes
35,398
shares in Mr. Maricondo’s own name and
9,133
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
1,475
shares of Restricted Stock (see number 21 below for grant details).
|
|
(9)
|
Includes
32,066
shares in Mr. Patel’s own name and
9,033
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
1,237
shares of Restricted Stock (see number 22 below for grant details).
|
|
(10)
|
Includes
12,650
shares in Mr. Souders’ own name and
9,033
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
1,237
shares of Restricted Stock (see number 22 below for grant details).
|
|
(11)
|
Includes
48,599
shares in Mr. Aaron Tucker's own name and
9,033
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
1,237
shares of Restricted Stock (see number 22 below for grant details).
|
|
(12)
|
Includes
359,622
shares in Mr. Allen Tucker’s own name and
9,133
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
1,475
shares of Restricted Stock (see number 21 below for grant details) and
549
shares issued through a Dividend Reinvestment Plan.
|
|
(13)
|
Includes
94,287
shares in Mr. Hughes’ own name,
9,432
shares held in his 401(k) and
41,001
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
28,875
shares of Restricted Stock (see number 24 below for grant details) and
824
shares issued through a Dividend Reinvestment Plan.
|
|
(14)
|
Includes
11,825
shares in Mr. Bedner’s own name,
4,114
shares held in his 401(k) and
58,012
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
9,613
shares of Restricted Stock (see number 23 below for grant details).
|
|
(15)
|
Includes
20,868
shares in Ms. Bolomey’s own name and
72,001
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
10,550
shares of Restricted Stock (see number 26 below for grant details).
|
|
(16)
|
Includes
52,590
shares in Mr. Kauchak’s own name and
65,001
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
10,050
shares of Restricted Stock (see number 25 below for grant details).
|
|
(17)
|
Includes
6,925
shares in Mr. Rooney's own name and
14,467
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
3,237
shares or Restricted Stock. (see number 27 below for grant details).
|
|
(18)
|
Includes
327,612
shares issuable upon the exercise of immediately exercisable options.
|
|
(19)
|
All information regarding the number of shares beneficially owned and the percent of ownership by Endicott Management Company was obtained from Bloomberg on February 25, 2020.
|
|
(20)
|
All information regarding the number of shares beneficially owned and the percent of ownership by Banc Funds Company LLC, was obtained from the 13G filed with the U.S. Securities and Exchange Commission on February 13, 2020.
|
|
(21)
|
The details of the restricted stock grants for all Directors holding
1,475
shares of Restricted Stock as of
February 24, 2020
are as follows:
|
|
•
|
350
shares remaining unvested of an original grant of
1,400
shares granted on
January 3, 2017
, which vest in
350
share increments over four (4) years commencing
January 3, 2018
; and
|
|
•
|
450
shares remaining unvested of an original grant of
900
shares granted on
January 2, 2018
, which vest in
225
share increments over four (4) years commencing
January 2, 2019
; and
|
|
•
|
675
shares remaining unvested of an original grant of
900
shares granted on
January 2, 2019
, which vest in
225
share increments over four (4) years commencing
January 2, 2020
.
|
|
(22)
|
The details of the restricted stock grants for all Directors holding
1,237
shares of Restricted Stock as of
February 24, 2020
are as follows:
|
|
•
|
300
shares remaining unvested of an original grant of
1,200
shares granted on
January 3, 2017
, which vest in
300
share increments over four (4) years commencing
January 3, 2018
; and
|
|
•
|
375
shares remaining unvested of an original grant of
750
shares granted on
January 2, 2018
, which vest in
187
share increments over four (4) years commencing
January 2, 2019
; and
|
|
•
|
562
shares remaining unvested of an original grant of
750
shares granted on
January 2, 2019
, which vest in
187
share increments over four (4) years commencing
January 2, 2020
.
|
|
(23)
|
The details of the restricted stock grants for all Executives holding
9,613
shares of Restricted Stock as of
February 24, 2020
are as follows:
|
|
•
|
550
shares remaining unvested of an original grant of
2,200
shares granted on
February 25, 2016
, which vest in
550
share increments over four (4) years commencing
February 25, 2017
; and
|
|
•
|
2,500
shares remaining unvested of an original grant of
5,000
shares granted on
March 3, 2017
, which vest in
1,250
share increments over four (4) years commencing
March 3, 2018
; and
|
|
•
|
2,813
shares remaining unvested of an original grant of
3,750
shares granted on
March 9, 2018
, which vest in
937
share increments over four (4) years commencing
March 9, 2019
; and
|
|
•
|
3,750
shares granted on
March 12, 2019
which vest in
937
share increments over four (4) years commencing
March 12, 2020
.
|
|
(24)
|
The details of the restricted stock grants for all Directors holding
28,875
shares of Restricted Stock as of
February 24, 2020
are as follows:
|
|
•
|
1,375
shares remaining unvested of an original grant of
5,500
shares granted on
February 25, 2016
, which vest in
1,375
share increments over four (4) years commencing
February 25, 2017
; and
|
|
•
|
4,000
shares remaining unvested of an original grant of
8,000
shares granted on
March 3, 2017
, which vest in
2,000
share increments over four (4) years commencing
March 3, 2018
; and
|
|
•
|
6,000
shares remaining unvested of an original grant of
8,000
shares granted on
March 9, 2018
, which vest in
2,000
share increments over four (4) years commencing
March 9, 2019
; and
|
|
•
|
10,000
shares granted on
March 12, 2019
which vest in
2,500
share increments over four (4) years commencing
March 12, 2020
; and
|
|
•
|
7,500
shares granted on
August 22, 2019
which vest in
1,875
share increments over four (4) years commencing
August 22, 2020
.
|
|
(25)
|
The details of the restricted stock grants for all Executives holding
10,050
shares of Restricted Stock as of
February 24, 2020
are as follows:
|
|
•
|
550
shares remaining unvested of an original grant of
2,200
shares granted on
February 25, 2016
, which vest in
550
share increments over four (4) years commencing
February 25, 2017
; and
|
|
•
|
2,500
shares remaining unvested of an original grant of
5,000
shares granted on
March 3, 2017
, which vest in
1,250
share increments over four (4) years commencing
March 3, 2018
; and
|
|
•
|
3,000
shares remaining unvested of an original grant of
4,000
shares granted on
March 9, 2018
, which vest in
1,000
share increments over four (4) years commencing
March 3, 2019
; and
|
|
•
|
4,000
shares granted on
March 12, 2019
which vest in
1,000
share increments over four (4) years commencing
March 12, 2020
.
|
|
•
|
550
shares remaining unvested of an original grant of
2,200
shares granted on
February 25, 2016
, which vest in
550
share increments over four (4) years commencing
February 25, 2017
; and
|
|
•
|
3,000
shares remaining unvested of an original grant of
6,000
shares granted on
March 3, 2017
, which vest in
1,500
share increments over four (4) years commencing
March 3, 2018
; and
|
|
•
|
3,000
shares remaining unvested of an original grant of
4,000
shares granted on
March 9, 2018
, which vest in
1,000
share increments over four (4) years commencing
March 9, 2019
; and
|
|
•
|
4,000
shares granted on
March 12, 2019
which vest in
1,000
share increments over four (4) years commencing
March 12, 2020
.
|
|
•
|
300
shares remaining unvested of an original grant of
1,200
shares granted on
December 15, 2016
, which vest in
300
share increments over four (4) years commencing
December 15, 2017
; and
|
|
•
|
750
shares remaining unvested of an original grant of
1,500
shares granted on
January 2, 2018
, which vest in
375
share increments over four (4) years commencing
January 2, 2019
; and
|
|
•
|
937
shares remaining unvested of an original grant of
1,250
shares granted on
December 10, 2018
, which vest in
312
share increments over four (4) years commencing
December 10, 2019
; and
|
|
•
|
1,250
shares granted on
December 6, 2019
which vest in
312
share increments over four (4) years commencing
December 6, 2020
.
|
|
Name
|
Title
|
|
James A. Hughes
|
President & Chief Executive Officer
|
|
Alan J. Bedner (1)
|
Executive Vice President & Chief Financial Officer
|
|
Janice Bolomey
|
Executive Vice President & Chief Administrative Officer
|
|
John J. Kauchak
|
Executive Vice President & Chief Operating Officer
|
|
Stephen Rooney (2)
|
1st Senior Vice President & Chief Lending Officer
|
|
(1)
|
Mr. Bedner resigned as Executive Vice President and Chief Financial Officer on January 24, 2020.
|
|
(2)
|
Mr. Rooney is considered an NEO as defined under SEC rules; however his compensation is not structured as discussed in the following CD&A. Mr. Rooney's cash bonus is discretionary.
|
|
|
Fiscal Year Ending
|
|||||||||||
|
|
12/31/2014
|
|
12/31/2015
|
|
12/31/2016
|
|
12/31/2017
|
|
12/31/2018
|
|
12/31/2019
|
|
|
Unity Bancorp, Inc.
|
100.00
|
|
134.14
|
|
188.41
|
|
240.09
|
|
255.44
|
|
281.75
|
|
|
KBW NASDAQ Bank Index
|
100.00
|
|
100.49
|
|
129.14
|
|
153.14
|
|
126.02
|
|
171.55
|
|
|
NASDAQ Composite Index
|
100.00
|
|
107.11
|
|
116.72
|
|
151.41
|
|
147.16
|
|
201.22
|
|
|
•
|
Net income increased $1.8 million to $23.7 million, or $2.14 per diluted share compared to $21.9 million, or $2.01 per diluted share from the prior year.
|
|
•
|
Net income before tax increased 11.0 percent to $30.3 million from $27.3 million in the prior year.
|
|
•
|
Net interest income increased $3.8 million, or 7.2 percent to $57.6 million from $53.7 million in the prior year, primarily due to strong loan growth.
|
|
•
|
Noninterest income was $9.5 million, a $508 thousand increase compared to $9.0 million in the prior year.
|
|
•
|
9.3 percent increase in total loans driven by a 21.1 percent increase in SBA loans held for sale, a 15.8 percent increase in consumer loans, a 10.2 percent increase in commercial loans and a 7.3 percent increase in residential mortgage loans.
|
|
•
|
3.5 percent increase in total deposits with a 13.2 percent increase in time deposits and a 3.6 percent increase in noninterest-bearing deposits.
|
|
•
|
Ensuring that our NEO’s maintain and hold a significant equity interest in the Company by making option and restricted stock grants a significant part of the total compensation mix, thereby further aligning management interests with those of the shareholders;
|
|
•
|
Creating balanced incentives that do not encourage NEOs to expose the Company to inappropriate risks by providing excessive compensation that could lead to material loss;
|
|
•
|
Providing a market competitive overall compensation package so that the Company may attract, retain and reward highly qualified, motivated and productive executives; and
|
|
•
|
Rewarding individuals of greatest responsibility and achievement within a framework that is internally equitable.
|
|
•
|
Pay for Performance - We provide a significant portion of pay based on performance
|
|
•
|
Sound Risk Management - We discourage excessive risk taking and have designed our incentive plans with appropriate risk-mitigating features
|
|
•
|
Claw back - We have adopted a claw back policy requiring the return of incentive compensation in the event of a financial restatement
|
|
•
|
Double-Trigger Change-in-Control (CIC) - CIC benefits pursuant to employment or change in control agreements are only paid upon a termination event following a CIC
|
|
•
|
Pay in Arrears - Our Directors' and Executives' incentive compensation is paid in arrears. For example, incentive compensation earned for fiscal year
2019
was paid in
2020
.
|
|
•
|
Tax Gross-Ups - We do not provide excise tax gross-ups on benefits or in change-in-control agreements
|
|
•
|
Stock Option Repricing - Our equity plan does not permit repricing of stock options that are out-of-the-money
|
|
Compensation Component
|
Purpose/Objective
|
|
|
Base Salary
|
•
|
Provides a competitive level of fixed income based on role, experience and individual performance
|
|
Annual Incentive Plan
|
•
|
Motivates and rewards executives for performance on key financial, operational and individual objectives in support of our annual business plan and broader corporate strategies
|
|
|
•
|
Rewards vary based on performance
|
|
Equity Awards
|
•
|
Aligns executives’ interests with those of shareholders through equity-based compensation
|
|
|
•
|
Rewards executives for long-term shareholder value creation
|
|
|
•
|
E
ncourages retention through multiple year vesting
|
|
Other Benefits
|
•
|
Provides a base level of competitive compensation for executive talent
|
|
Employment Agreements/
|
•
|
Provides
employment security to key executives
|
|
Severance & CIC
Agreements
|
•
|
Focuses executives on company performance and transactions that are in the best interests of shareholders, regardless of the impact such transactions may have on the executive’s employment
|
|
Retirement Benefits
|
•
|
The Supplemental Executive Retirement Plan (the "SERP") provides long term compensation for our CEO while its vesting provisions ensure that the Company will continue to receive the benefit of his service
|
|
|
•
|
The Executive Incentive Retirement Plan (the "EIRP") provides long term compensation for our other key executives
|
|
Executive
|
2018 Base Salary
|
2019 Base Salary
|
Increase
|
|||||
|
James A. Hughes
|
$
|
470,002
|
|
$
|
550,673
|
|
17.16
|
%
|
|
Alan J. Bedner
|
$
|
211,753
|
|
$
|
218,105
|
|
3.00
|
%
|
|
Janice Bolomey
|
$
|
200,000
|
|
$
|
208,000
|
|
4.00
|
%
|
|
John J. Kauchak
|
$
|
202,501
|
|
$
|
208,575
|
|
3.00
|
%
|
|
Stephen Rooney
|
$
|
204,000
|
|
$
|
212,000
|
|
3.92
|
%
|
|
Executive
|
Target Aggregate Incentive Opportunity
|
|
|
James A. Hughes
|
60.00
|
%
|
|
Alan J. Bedner
|
—
|
|
|
Janice Bolomey
|
37.50
|
%
|
|
John J. Kauchak
|
37.50
|
%
|
|
Performance Measure
|
Weight
|
Threshold (75%)
|
Target (100%)
|
Cap (150%)
|
||||
|
Growth in Net Income Before Tax
|
20.00
|
%
|
6.00
|
%
|
8.00
|
%
|
12.00
|
%
|
|
Return on Average Assets (ROA) vs. Peer (1)
|
20.00
|
%
|
75.00
|
%
|
100.00
|
%
|
150.00
|
%
|
|
Return on Average Equity (ROE) vs. Peer (1)
|
20.00
|
%
|
75.00
|
%
|
100.00
|
%
|
150.00
|
%
|
|
Performance Measure
|
2019 Performance
|
Result
|
Payout Factor
|
||
|
Growth in Net Income Before Tax
|
11.02
|
%
|
Target
|
138.00
|
%
|
|
Return on Average Assets (ROA) vs. Peer (1)
|
136.3% of peer
|
|
Target
|
136.00
|
%
|
|
Return on Average Equity (ROE) vs. Peer (1)
|
154.3% of peer
|
|
Cap
|
150.00
|
%
|
|
Executive
|
2019 Target Annual Incentive Award
|
2019 Actual Annual Incentive Award
|
2019 Actual as % of Target
|
|||||
|
James A. Hughes
|
$
|
330,404
|
|
$
|
359,667
|
|
109
|
%
|
|
Alan J. Bedner
|
$
|
—
|
|
$
|
—
|
|
—
|
|
|
Janice Bolomey
|
$
|
78,000
|
|
$
|
92,708
|
|
119
|
%
|
|
John J. Kauchak
|
$
|
78,216
|
|
$
|
92,964
|
|
119
|
%
|
|
|
Option Awards
|
Restricted Stock
|
||||||
|
Executive
|
# Shares
|
Grant Value ($)
|
# Shares
|
Grant Value ($)
|
||||
|
James A. Hughes
|
25,000
|
|
155,282
|
|
17,500
|
|
356,100
|
|
|
Alan J. Bedner
|
10,000
|
|
62,113
|
|
3,750
|
|
77,288
|
|
|
Janice Bolomey
|
10,000
|
|
62,113
|
|
4,000
|
|
82,440
|
|
|
John J. Kauchak
|
10,000
|
|
62,113
|
|
4,000
|
|
82,440
|
|
|
•
|
By the end of a director’s third year of board service, he/she must own Company stock valued at $50,000. Board members must continue to maintain this minimum level of stock ownership throughout their tenure as a director.
|
|
•
|
This requirement may be satisfied through the exercise of stock options, participation in distributions undertaken by the Company, or open market purchases.
|
|
Name and Principal Position
|
Year
|
Salary ($)
|
Stock Awards ($)*
|
Option Awards ($)**
|
Non-equity (Cash) Incentive Plan Compensation ($)
|
Primary Compensation Total ($)
|
All Other Compensation ($)
|
Total ($)
|
|||||||
|
|
|
|
(2)
|
(2)
|
(1)
|
(3)
|
(4)
|
|
|||||||
|
James A. Hughes
|
2019
|
550,673
|
|
356,100
|
|
155,282
|
|
359,667
|
|
1,421,722
|
|
898,276
|
|
2,319,998
|
|
|
President/CEO
|
2018
|
470,002
|
|
180,000
|
|
147,072
|
|
182,713
|
|
979,787
|
|
1,619,004
|
|
2,598,791
|
|
|
|
2017
|
442,924
|
|
134,000
|
|
—
|
|
210,389
|
|
787,313
|
|
208,632
|
|
995,945
|
|
|
Alan J. Bedner
|
2019
|
218,105
|
|
77,288
|
|
62,113
|
|
—
|
|
357,506
|
|
31,021
|
|
388,527
|
|
|
EVP/CFO
|
2018
|
211,753
|
|
84,375
|
|
67,833
|
|
61,739
|
|
425,700
|
|
61,023
|
|
486,723
|
|
|
|
2017
|
205,553
|
|
83,750
|
|
46,952
|
|
60,741
|
|
396,996
|
|
56,978
|
|
453,974
|
|
|
Janice Bolomey
|
2019
|
208,000
|
|
82,440
|
|
62,113
|
|
92,708
|
|
445,261
|
|
60,651
|
|
505,912
|
|
|
EVP/Chief Admin.
|
2018
|
200,000
|
|
90,000
|
|
67,833
|
|
62,063
|
|
419,896
|
|
63,098
|
|
482,994
|
|
|
Officer
|
2017
|
190,193
|
|
100,500
|
|
46,952
|
|
70,181
|
|
407,826
|
|
57,721
|
|
465,547
|
|
|
John J. Kauchak
|
2019
|
208,575
|
|
82,440
|
|
62,113
|
|
92,964
|
|
446,092
|
|
67,079
|
|
513,171
|
|
|
EVP/COO
|
2018
|
202,501
|
|
90,000
|
|
67,833
|
|
60,940
|
|
421,274
|
|
57,561
|
|
478,835
|
|
|
|
2017
|
195,000
|
|
83,750
|
|
46,952
|
|
65,228
|
|
390,930
|
|
50,123
|
|
441,053
|
|
|
Stephen Rooney
|
2019
|
212,000
|
|
27,813
|
|
30,944
|
|
30,000
|
|
300,757
|
|
20,782
|
|
321,539
|
|
|
1st SVP/CLO
|
2018
|
212,000
|
|
56,775
|
|
74,250
|
|
30,000
|
|
373,025
|
|
21,468
|
|
394,493
|
|
|
|
2017
|
204,000
|
|
—
|
|
—
|
|
35,000
|
|
239,000
|
|
18,324
|
|
257,324
|
|
|
(1)
|
Of these awards, $300,000 of Mr. Hughes
2019
non-equity incentive plan award, $150,000 of the
2018
non-equity incentive plan award, and $105,195 of the
2017
non-equity incentive plan award was deposited into his deferred compensation plan. Mr. Rooney's non-equity bonus represents a discretionary cash bonus and is not included in the non-equity incentive plan.
|
|
(2)
|
Represents the full grant date fair value of the award. See Note 18 to our audited financial statements. The awards are subject to vesting requirements.
|
|
(3)
|
Represents executive's salary and both equity and non-equity compensation plans.
|
|
(4)
|
In 2018, Mr. Hughes’ other compensation included $1,560,596 allocated under the SERP plan, of which $1,385,000 was related to an adjustment in accrual methodology and an increase in benefit calculation from 40% to 60% of Mr. Hughes' base salary. An additional adjustment was made in 2019 to account for Mr. Hughes' increase in salary.
|
|
Name
|
Year
|
SERP/EIRP Contributions ($)
|
Other* ($)
|
Total Other Compensation ($)
|
|||
|
James A. Hughes
|
2019
|
823,338
|
|
74,938
|
|
898,276
|
|
|
President/CEO
|
2018
|
1,560,596
|
|
58,408
|
|
1,619,004
|
|
|
|
2017
|
164,103
|
|
44,529
|
|
208,632
|
|
|
Alan J. Bedner
|
2019
|
8,133
|
|
22,888
|
|
31,021
|
|
|
EVP/CFO
|
2018
|
36,620
|
|
24,403
|
|
61,023
|
|
|
|
2017
|
33,696
|
|
23,282
|
|
56,978
|
|
|
Janice Bolomey
|
2019
|
38,489
|
|
22,162
|
|
60,651
|
|
|
EVP/Chief Admin.
|
2018
|
34,279
|
|
28,819
|
|
63,098
|
|
|
Officer
|
2017
|
31,001
|
|
26,720
|
|
57,721
|
|
|
John J. Kauchak
|
2019
|
38,889
|
|
28,190
|
|
67,079
|
|
|
EVP/COO
|
2018
|
34,882
|
|
22,679
|
|
57,561
|
|
|
|
2017
|
31,883
|
|
18,240
|
|
50,123
|
|
|
Steve Rooney
|
2019
|
—
|
|
20,782
|
|
20,782
|
|
|
1st SVP/CLO
|
2018
|
—
|
|
21,468
|
|
21,468
|
|
|
|
2017
|
—
|
|
18,324
|
|
18,324
|
|
|
Name
|
Grant Date
|
Approval Date
|
Estimated future payouts under non-equity incentive plan awards
|
Grant Type
|
Stock Awards: Shares of Stock or Units (#)
|
Option Awards: Securities Underlying Options (#)
|
Exercise or Base Price of Option or Stock Awards ($)
|
Market Price on Grant Date ($)
|
Grant Date Fair Value of Stock and Options Awards ($)
|
||||||||||
|
|
(1)
|
|
Threshold (2)
|
Target
|
Max (3)
|
|
(4)
|
(5)
|
(6)
|
(6)
|
|
||||||||
|
James A. Hughes
|
3/12/2020
|
2/27/2020
|
247,803
|
|
330,404
|
|
429,525
|
|
|
|
|
|
|
|
|||||
|
|
3/12/2019
|
1/24/2019
|
|
|
|
Stock Options
|
|
25,000
|
|
20.61
|
|
20.61
|
|
155,282
|
|
||||
|
|
3/12/2019
|
1/24/2019
|
|
|
|
Restricted stock
|
10,000
|
|
|
|
|
|
20.61
|
|
206,100
|
|
|||
|
|
8/22/2019
|
8/22/2019
|
|
|
|
Restricted stock
|
7,500
|
|
|
|
20.00
|
|
150,000
|
|
|||||
|
Alan J. Bedner
|
3/12/2019
|
1/24/2019
|
|
|
|
Stock Options
|
|
10,000
|
|
20.61
|
|
20.61
|
|
62,113
|
|
||||
|
|
3/12/2019
|
1/24/2019
|
|
|
|
Restricted stock
|
3,750
|
|
|
|
20.61
|
|
77,288
|
|
|||||
|
Janice Bolomey
|
3/12/2020
|
2/27/2020
|
58,500
|
|
78,000
|
|
101,400
|
|
|
|
|
|
|
|
|||||
|
|
3/12/2019
|
1/24/2019
|
|
|
|
Stock Options
|
|
10,000
|
|
20.61
|
|
20.61
|
|
62,113
|
|
||||
|
|
3/12/2019
|
1/24/2019
|
|
|
|
Restricted stock
|
4,000
|
|
|
|
20.61
|
|
82,440
|
|
|||||
|
John J. Kauchak
|
3/12/2020
|
2/27/2020
|
58,662
|
|
78,216
|
|
101,680
|
|
|
|
|
|
|
|
|||||
|
|
3/12/2019
|
1/24/2019
|
|
|
|
Stock Options
|
|
10,000
|
|
20.61
|
|
20.61
|
|
62,113
|
|
||||
|
|
3/12/2019
|
1/24/2019
|
|
|
|
Restricted stock
|
4,000
|
|
|
|
20.61
|
|
82,440
|
|
|||||
|
Stephen Rooney
|
12/6/2019
|
12/6/2019
|
|
|
|
Stock Options
|
|
5,000
|
|
22.25
|
|
22.25
|
|
30,944
|
|
||||
|
|
12/6/2019
|
12/6/2019
|
|
|
|
Restricted stock
|
1,250
|
|
|
|
22.25
|
|
27,813
|
|
|||||
|
|
Option Awards
|
Stock Awards
|
||||||||
|
Name
|
Number of shares acquired on exercise (#)
|
Value realized on exercise ($)
|
Number of shares acquired on vesting (#)
|
Value realized on vesting ($)
|
||||||
|
James A. Hughes
|
—
|
|
$
|
—
|
|
6,035
|
|
$
|
127,948
|
|
|
Alan J. Bedner
|
6,000
|
|
85,877
|
|
3,287
|
|
70,138
|
|
||
|
Janice Bolomey
|
—
|
|
—
|
|
3,600
|
|
76,998
|
|
||
|
John J. Kauchak
|
14,800
|
|
230,775
|
|
3,350
|
|
71,438
|
|
||
|
Stephen Rooney
|
2,700
|
|
30,809
|
|
1,401
|
|
31,672
|
|
||
|
Name
|
Plan
|
Executive Contributions in Last FY ($)
|
Registrant Contributions in Last FY ($)
|
Aggregate Earnings in Last FY ($)
|
Aggregate Withdrawals/Distributions ($)
|
Aggregate balance at last FYE ($)
|
|||||
|
James A. Hughes
|
SERP
|
—
|
|
823,338
|
|
—
|
|
—
|
|
3,570,774
|
|
|
Name
|
Plan
|
Executive Contributions in Last FY
|
Registrant Contributions in Last FY
|
Aggregate Earnings in Last FY
|
Aggregate Withdrawals/Distributions
|
Aggregate balance at last FYE
|
||||||||||
|
Alan J. Bedner
|
EIRP
|
$
|
—
|
|
$
|
39,896
|
|
$
|
—
|
|
$
|
—
|
|
$
|
138,733
|
|
|
Janice Bolomey
|
EIRP
|
—
|
|
37,289
|
|
—
|
|
—
|
|
124,611
|
|
|||||
|
John J. Kauchak
|
EIRP
|
—
|
|
37,977
|
|
—
|
|
—
|
|
129,803
|
|
|||||
|
OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END (12/31/19)
|
|||||||||||||||||
|
Option Awards
|
Stock Awards
|
||||||||||||||||
|
Name
|
Number of Securities Underlying Unexercised Options Exercisable (#)
|
Number of Securities Underlying Unexercised Options Unexercisable (#)
|
Equity Incentive Plan Awards; Number of Securities Underlying Unexercised Unearned Options (#)
|
Option Exercise Price ($)
|
Option Expiration Date
|
Number of Shares or Units of Stock That Have Not Vested (#)
|
Market Value of Shares or Units of Stock That Have Not Vested ($)
|
Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#)
|
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested (#)
|
||||||||
|
James A. Hughes
|
11,000
|
|
—
|
|
—
|
|
7.25
|
|
3/27/2024
|
1,375
|
|
31,034
|
|
—
|
|
—
|
|
|
|
11,000
|
|
—
|
|
—
|
|
8.31
|
|
1/29/2025
|
4,000
|
|
90,280
|
|
—
|
|
—
|
|
|
|
11,000
|
|
—
|
|
—
|
|
8.95
|
|
2/25/2026
|
6,000
|
|
135,420
|
|
—
|
|
—
|
|
|
|
3,334
|
|
6,666
|
|
—
|
|
21.15
|
|
3/9/2028
|
10,000
|
|
225,700
|
|
—
|
|
—
|
|
|
|
4,667
|
|
9,333
|
|
—
|
|
18.77
|
|
12/21/2028
|
7,500
|
|
169,275
|
|
—
|
|
—
|
|
|
|
—
|
|
25,000
|
|
—
|
|
20.61
|
|
3/12/2029
|
—
|
|
—
|
|
—
|
|
—
|
|
|
Alan J. Bedner
|
15,011
|
|
—
|
|
—
|
|
5.48
|
|
3/5/2023
|
550
|
|
12,414
|
|
—
|
|
—
|
|
|
|
11,000
|
|
—
|
|
—
|
|
7.16
|
|
3/3/2024
|
2,500
|
|
56,425
|
|
—
|
|
—
|
|
|
|
11,000
|
|
—
|
|
—
|
|
8.29
|
|
3/17/2025
|
2,813
|
|
63,489
|
|
—
|
|
—
|
|
|
|
11,000
|
|
—
|
|
—
|
|
8.95
|
|
2/25/2026
|
3,750
|
|
84,638
|
|
—
|
|
—
|
|
|
|
6,667
|
|
3,333
|
|
—
|
|
16.75
|
|
3/3/2027
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
3,334
|
|
6,666
|
|
—
|
|
21.15
|
|
3/9/2028
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
—
|
|
10,000
|
|
—
|
|
20.61
|
|
3/12/2029
|
—
|
|
—
|
|
—
|
|
—
|
|
|
Janice Bolomey
|
7,000
|
|
—
|
|
—
|
|
6.06
|
|
5/26/2021
|
550
|
|
12,414
|
|
—
|
|
—
|
|
|
|
11,000
|
|
—
|
|
—
|
|
5.82
|
|
11/17/2021
|
3,000
|
|
67,710
|
|
—
|
|
—
|
|
|
|
11,000
|
|
—
|
|
—
|
|
5.46
|
|
12/18/2022
|
3,000
|
|
67,710
|
|
—
|
|
—
|
|
|
|
11,000
|
|
—
|
|
—
|
|
7.16
|
|
3/3/2024
|
4,000
|
|
90,280
|
|
—
|
|
—
|
|
|
|
11,000
|
|
—
|
|
—
|
|
8.29
|
|
3/17/2025
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
11,000
|
|
—
|
|
—
|
|
8.95
|
|
2/25/2026
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
6,667
|
|
3,333
|
|
—
|
|
16.75
|
|
3/3/2027
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
3,334
|
|
6,666
|
|
—
|
|
21.15
|
|
3/9/2028
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
—
|
|
10,000
|
|
—
|
|
20.61
|
|
3/12/2029
|
—
|
|
—
|
|
—
|
|
—
|
|
|
John J. Kauchak
|
11,000
|
|
—
|
|
—
|
|
5.82
|
|
11/17/2021
|
550
|
|
12,414
|
|
—
|
|
—
|
|
|
|
11,000
|
|
—
|
|
—
|
|
5.48
|
|
3/5/2023
|
2,500
|
|
56,425
|
|
—
|
|
—
|
|
|
|
11,000
|
|
—
|
|
—
|
|
7.16
|
|
3/3/2024
|
3,000
|
|
67,710
|
|
—
|
|
—
|
|
|
|
11,000
|
|
—
|
|
—
|
|
8.29
|
|
3/17/2025
|
4,000
|
|
90,280
|
|
—
|
|
—
|
|
|
|
11,000
|
|
—
|
|
—
|
|
8.95
|
|
2/25/2026
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
6,667
|
|
3,333
|
|
—
|
|
16.75
|
|
3/3/2027
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
3,334
|
|
6,666
|
|
—
|
|
21.15
|
|
3/9/2028
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
—
|
|
10,000
|
|
—
|
|
20.61
|
|
3/12/2029
|
—
|
|
—
|
|
—
|
|
—
|
|
|
Stephen Rooney
|
2,800
|
|
—
|
|
—
|
|
9.63
|
|
12/16/2025
|
300
|
|
6,771
|
|
—
|
|
—
|
|
|
|
5,000
|
|
—
|
|
—
|
|
14.60
|
|
12/15/2026
|
1,125
|
|
25,391
|
|
—
|
|
—
|
|
|
|
2,500
|
|
5,000
|
|
—
|
|
19.75
|
|
1/2/2028
|
937
|
|
21,148
|
|
—
|
|
—
|
|
|
|
1,667
|
|
3,333
|
|
—
|
|
21.30
|
|
12/10/2028
|
1,250
|
|
28,213
|
|
—
|
|
—
|
|
|
|
—
|
|
5,000
|
|
—
|
|
22.25
|
|
12/6/2029
|
—
|
|
—
|
|
—
|
|
—
|
|
|
Payments and Benefits
|
Termination without cause
|
Termination following a change in control
|
||||
|
Cash Compensation - Change in Control
|
$
|
826,010
|
|
$
|
1,185,676
|
|
|
Cash Compensation - Non-compete
|
|
|
1,185,676
|
|
||
|
Health Benefits
|
19,037
|
|
19,037
|
|
||
|
Accelerated Option Vesting
|
—
|
|
253,323
|
|
||
|
Accelerated Restricted Stock Vesting
|
—
|
|
570,400
|
|
||
|
SERP Contribution
|
—
|
|
522,683
|
|
||
|
Total
|
$
|
845,046
|
|
$
|
3,736,795
|
|
|
Payments and Benefits
|
Termination without cause
|
Termination following a change in control
|
||||
|
Cash Compensation
|
$
|
208,000
|
|
$
|
508,708
|
|
|
Health Benefits
|
12,507
|
|
25,015
|
|
||
|
Accelerated Vesting of Stock Options
|
—
|
|
122,979
|
|
||
|
Accelerated Vesting of Restricted Stock
|
—
|
|
205,110
|
|
||
|
Total
|
$
|
220,507
|
|
$
|
861,812
|
|
|
Payments and Benefits
|
Termination without cause
|
Termination following a change in control
|
||||
|
Cash Compensation
|
$
|
208,575
|
|
$
|
510,114
|
|
|
Health Benefits
|
6,483
|
|
12,966
|
|
||
|
Accelerated Vesting of Stock Options
|
—
|
|
122,979
|
|
||
|
Accelerated Vesting of Restricted Stock
|
—
|
|
196,735
|
|
||
|
Total
|
$
|
215,058
|
|
$
|
842,794
|
|
|
Payments and Benefits
|
Termination without cause
|
Termination following a change in control
|
||||
|
Cash Compensation
|
$
|
212,000
|
|
$
|
454,000
|
|
|
Health Benefits
|
12,986
|
|
25,972
|
|
||
|
Accelerated Vesting of Stock Options
|
—
|
|
80,622
|
|
||
|
Accelerated Vesting of Restricted Stock
|
—
|
|
74,898
|
|
||
|
Total
|
$
|
224,986
|
|
$
|
635,492
|
|
|
Name
|
Fees Earned or Paid in Cash
|
Stock Awards (1)
|
Option Awards (1)
|
All Other Compensation (2)
|
Total
|
||||||||||
|
Dr. Mark S. Brody
|
$
|
13,500
|
|
$
|
18,684
|
|
$
|
—
|
|
$
|
15,000
|
|
$
|
47,184
|
|
|
Wayne Courtright
|
21,300
|
|
18,684
|
|
—
|
|
12,000
|
|
51,984
|
|
|||||
|
David D. Dallas
|
21,100
|
|
18,684
|
|
—
|
|
18,000
|
|
57,784
|
|
|||||
|
Robert H. Dallas, II
|
18,400
|
|
15,570
|
|
—
|
|
12,000
|
|
45,970
|
|
|||||
|
Dr. Mary E. Gross
|
15,100
|
|
18,684
|
|
—
|
|
15,000
|
|
48,784
|
|
|||||
|
Peter E. Maricondo
|
16,300
|
|
18,684
|
|
—
|
|
15,000
|
|
49,984
|
|
|||||
|
Raj Patel
|
16,900
|
|
15,570
|
|
—
|
|
12,000
|
|
44,470
|
|
|||||
|
Donald E. Souders, Jr.
|
10,800
|
|
15,570
|
|
—
|
|
12,000
|
|
38,370
|
|
|||||
|
Aaron Tucker
|
19,600
|
|
15,570
|
|
—
|
|
12,000
|
|
47,170
|
|
|||||
|
Allen Tucker
|
22,800
|
|
18,684
|
|
—
|
|
15,000
|
|
56,484
|
|
|||||
|
Name
|
Number of shares of Restricted Stock Awarded
|
Grant Date Fair Value of Stock Awarded
|
Number of Options Awarded
|
Grant Date Fair Value of Options Awarded
|
Aggregate Number of Restricted Stock Awards Outstanding
|
Aggregate Number of Options Outstanding
|
||||||||
|
Dr. Mark S. Brody
|
900
|
|
$
|
18,684
|
|
—
|
|
$
|
—
|
|
2,715
|
|
12,200
|
|
|
Wayne Courtright
|
900
|
|
18,684
|
|
—
|
|
—
|
|
2,715
|
|
12,200
|
|
||
|
David D. Dallas
|
900
|
|
18,684
|
|
—
|
|
—
|
|
2,715
|
|
6,733
|
|
||
|
Robert H. Dallas, II
|
750
|
|
15,570
|
|
—
|
|
—
|
|
2,353
|
|
6,700
|
|
||
|
Dr. Mary E. Gross
|
900
|
|
18,684
|
|
—
|
|
—
|
|
2,715
|
|
9,267
|
|
||
|
Peter E. Maricondo
|
900
|
|
18,684
|
|
—
|
|
—
|
|
2,715
|
|
12,200
|
|
||
|
Raj Patel
|
750
|
|
15,570
|
|
—
|
|
—
|
|
2,353
|
|
12,100
|
|
||
|
Donald E. Souders, Jr.
|
750
|
|
15,570
|
|
—
|
|
—
|
|
2,353
|
|
12,100
|
|
||
|
Aaron Tucker
|
750
|
|
15,570
|
|
—
|
|
—
|
|
2,353
|
|
12,100
|
|
||
|
Allen Tucker
|
900
|
|
18,684
|
|
—
|
|
—
|
|
2,715
|
|
12,200
|
|
||
|
Name
|
Deferred Compensation
|
Interest Received
|
Total
|
||||||
|
Dr. Mark S. Brody
|
$
|
28,500
|
|
$
|
28,673
|
|
$
|
57,173
|
|
|
Peter Maricondo
|
31,300
|
|
4,428
|
|
35,728
|
|
|||
|
David D. Dallas
|
39,100
|
|
4,813
|
|
43,913
|
|
|||
|
Robert H. Dallas, II
|
30,400
|
|
2,434
|
|
32,834
|
|
|||
|
Aaron Tucker
|
15,800
|
|
1,742
|
|
17,542
|
|
|||
|
Donald Souders
|
22,800
|
|
1,121
|
|
23,921
|
|
|||
|
James. A. Hughes
|
150,000
|
|
44,659
|
|
194,659
|
|
|||
|
John J. Kauchak
|
60,940
|
|
11,285
|
|
72,225
|
|
|||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|